Compounds > clofazimine

clofazimine and piperidines

clofazimine has been researched along with piperidines in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Franzblau, SG; O'Sullivan, JF; White, KE1
Anderson, R; Jooné, G; Myer, MS; O'Sullivan, JF; Van Rensburg, CE1
Huygens, F; O'Sullivan, JF; van Rensburg, CE1
Adamson, JH; Cumming, BM; Finin, PM; Jonnala, SR; Lamprecht, DA; Rahman, MA; Russell, SL; Steyn, AJ1
Chun, DY; Einolf, HJ; Gu, H; Sangana, R1
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J1
Barkan, D; Moraski, GC; Pethe, K; Sorayah, R1

Other Studies

7 other study(ies) available for clofazimine and piperidines

ArticleYear
Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:11

    Topics: Anti-Bacterial Agents; Clofazimine; Microbial Sensitivity Tests; Mycobacterium leprae; Phenazines; Piperidines; Structure-Activity Relationship

1989
Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line.
    Anti-cancer drugs, 1997, Volume: 8, Issue:7

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clofazimine; Drug Resistance, Multiple; Humans; Leukemia; Molecular Structure; Phenazines; Piperidines; Structure-Activity Relationship; Tumor Cells, Cultured; Vinblastine

1997
Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.
    Chemotherapy, 2005, Volume: 51, Issue:5

    Topics: Clofazimine; Drug Resistance, Multiple; Enterococcus; Leprostatic Agents; Methicillin Resistance; Microbial Sensitivity Tests; Phenazines; Piperidines; Staphylococcus aureus; Streptococcus pneumoniae

2005
Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.
    Nature communications, 2016, 08-10, Volume: 7

    Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Electron Transport Chain Complex Proteins; Hep G2 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Macrophages; Mice; Mutation; Mycobacterium tuberculosis; Piperidines; Pyridines; RAW 264.7 Cells; Reactive Oxygen Species; Tuberculosis, Multidrug-Resistant

2016
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches.
    Drug metabolism and disposition: the biological fate of chemicals, 2018, Volume: 46, Issue:1

    Topics: Antitubercular Agents; Area Under Curve; Carbamates; Clofazimine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Drug Interactions; Humans; Midazolam; Models, Biological; Piperidines; Tuberculosis, Multidrug-Resistant

2018
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin

2019
The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2021, 11-17, Volume: 65, Issue:12

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Piperidines; Pyridines

2021